Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can smarter software make hearing implants easier to tune?

NCT ID NCT07763873

Knowledge-focused Sponsor: Cochlear Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study looks at how well new software helps clinicians adjust auditory implants for people with hearing loss. About 200 participants—including implant recipients and hearing healthcare professionals—will use the software in everyday clinic settings. The goal is to see how easily clinicians can complete fitting tasks and to identify any usability problems. Findings could guide improvements in software design and user experience.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Next-generation auditory implant fitting software and a companion smartphone app
What this could lead to
If successful, this could lead to more user-friendly fitting software, helping clinicians fine-tune implants more easily and improving hearing outcomes for patients.
What could go wrong
This is an early-stage usability study, not a test of medical effectiveness. Results may not reflect long-term benefits, and software issues could still arise after broader use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Jun 2030

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Recipient-Participant 1. Implanted with an auditory implant in one or both ears. 2. Aged 18 years or older. 3. Willing and able to provide written informed consent. Inclusion Criteria: Clinician-Participant 1. Tertiary qualification in a hearing healthcare discipline recognised for auditory implant or hearing aid fitting 2. At least 2 months' experience working with people with hearing impairment. 3. Willingness to participate in and to comply with all requirements of the protocol. Exclusion Criteria: Recipient-Participant 1. Additional disabilities that would prevent participation in evaluations. 2. Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator. 3. Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling. 4. Cochlear employees or employees of Contract Research Organizations or contractors engaged by Cochlear for the purposes of this investigation. 5. Current participation, or participation in another interventional clinical study/trial in the past 30 days, involving an investigational drug or device (unless Cochlear sponsored and determined by Investigator or Sponsor to not impact this investigation). Exclusion Criteria: Clinician-Participant 1\) Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hearing impairment are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hearing impairment

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Cochlear Limited

    Sydney, New South Wales, 2109, Australia

  • Denver Research and Technology Lab

    Lone Tree, Colorado, 80124, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.